Jon is a Senior Analyst at Asymmetry Group supporting clients across rare disease commercialization, launch planning, and commercial transformation initiatives. He brings a structured, execution-oriented approach to helping teams navigate complex commercial challenges.
Jon has contributed to launch strategy and commercialization efforts across a broad range of rare disease programs. His experience includes customer journey strategy, sales enablement, value narrative development, and cross-functional coordination, enabling improved commercial decision-making and alignment.
Jon holds a Bachelor of Arts degree in Economics with a minor in Finance from Boston College.
